Access the full text.
Sign up today, get DeepDyve free for 14 days.
L. Rubin, J. Staddon (1999)
The cell biology of the blood-brain barrier.Annual review of neuroscience, 22
Jeffrey Rothstein, Lynn Bristol, B. Hosler, Robert Brown, R. Kuncl (1994)
Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons.Proceedings of the National Academy of Sciences of the United States of America, 91 10
C. Mytilineou, P. Radcliffe, E. Leonardi, P. Werner, C. Olanow (1997)
l‐Deprenyl Protects Mesencephalic Dopamine Neurons from Glutamate Receptor‐Mediated Toxicity In VitroJournal of Neurochemistry, 68
Hansen Van, Zandt Law, W. Briles, Longen-Ecker Pazderka, J. Gavora, R Spencer, Ruth, W Brilei, R Stone, Science, W Droege, Miggieno Hala, Ziegler, D. Ewert, W Gilmour, M Vilhelmovb, J Maggiano, K. Pink, J Hkla, Eiiv Hartmanovi, M Simonsen, In Hkla, A. Benedict, Plenum, I. Doherty, R. Zinkernagle (1983)
Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.Science, 219 4587
M. Polymeropoulos, J. Higgins, L. Golbe, W. Johnson, S. Ide, G. Iorio, G. Sanges, E. Stenroos, L. Pho, A. Schaffer, A. Lazzarini, R. Nussbaum, R. Duvoisin (1996)
Mapping of a Gene for Parkinson's Disease to Chromosome 4q21-q23Science, 274
S. Susin, N. Zamzami, M. Castedo, T. Hirsch, P. Marchetti, A. Macho, E. Daugas, M. Geuskens, G. Kroemer (1996)
Bcl-2 inhibits the mitochondrial release of an apoptogenic proteaseThe Journal of Experimental Medicine, 184
P. Anglade, S. Vyas, F. Javoy‐Agid, M. Herrero, P. Michel, J. Marquez, A. Mouatt‐Prigent, M. Ruberg, E. Hirsch, Y. Agid (1997)
Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.Histology and histopathology, 12 1
Kevin Lee, T. Jessell (1999)
The specification of dorsal cell fates in the vertebrate central nervous system.Annual review of neuroscience, 22
R. Levi‐montalcini, V. Hamburger (1953)
A diffusible agent of mouse sarcoma, producing hyperplasia of sympathetic ganglia and hyperneurotization of viscera in the chick embryoJournal of Experimental Zoology, 123
D. Gash, Zhiming Zhang, Greg Gerhardt (1998)
Neuroprotective and neurorestorative properties of GDNFAnnals of Neurology, 44
A. Schapira, J. Cooper, D. Dexter, J. Clark, P. Jenner, C. Marsden (1990)
Mitochondrial Complex I Deficiency in Parkinson's DiseaseJournal of Neurochemistry, 54
U. Wüllner, P. Löschmann, J. Schulz, Annette Schmid, R. Dringen, Frank Eblen, L. Turski, T. Klockgether (1996)
Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neuronesNeuroReport, 7
Z. Alam, S. Daniel, A. Lees, D. Marsden, P. Jenner, B. Halliwell (1997)
A Generalised Increase in Protein Carbonyls in the Brain in Parkinson's but Not Incidental Lewy Body DiseaseJournal of Neurochemistry, 69
T. Gasser, MD” Wszolek, PhD Trofatter, BS Ozelius, MD Uitti, MD Lee, J. Gusella, MD Pfeiffer, MDn Calne, PhDV Breakefield, D. Gasser (1994)
Genetic linkage studies in autosomal dominant parkinsonism: Evaluation of seven candidate genesAnnals of Neurology, 36
R. Krüger, W. Kuhn, T. Müller, D. Woitalla, M. Graeber, S. Kösel, H. Przuntek, J. Epplen, L. Schols, O. Riess (1998)
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 18
P. Jenner, C. Olanow (1996)
Oxidative stress and the pathogenesis of Parkinson's diseaseNeurology, 47
Y. Agid (1995)
[Aging, disease and nerve cell death].Bulletin de l'Academie nationale de medecine, 179 6
C. Mytilineou, Leonardi Ek, P. Radcliffe, Heinonen Eh, Han Sk, P. Werner, G. Cohen, Olanow Cw (1998)
Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity induced by glutathione depletion.The Journal of pharmacology and experimental therapeutics, 284 2
R. Swerdlow, J. Parks, Scott Miller, R. Davis, J. Tuttle, P. Trimmer, J. Sheehan, J. Bennett, W. Parker (1996)
Origin and functional consequences of the complex I defect in Parkinson's diseaseAnnals of Neurology, 40
W. Tatton (1996)
Modulation of gene expression rather than monoamine oxidase inhibitionNeurology, 47
Steven Johnson, V. Seutin, R. North (1992)
Burst firing in dopamine neurons induced by N-methyl-D-aspartate: role of electrogenic sodium pump.Science, 258 5082
D. Dexter, A. Holley, W. Flitter, T. Slater, F. Wells, S. Daniel, A. Lees, P. Jenner, C. Marsden (1994)
Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: An HPLC and ESR studyMovement Disorders, 9
C. Olanow, M. Youdim (1996)
Iron and neurodegeneration
H. Ischiropoulos, Ling Zhu, Jun Chen, Michael Tsai, James Martin, Craig Smith, J. Beckman (1992)
Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase.Archives of biochemistry and biophysics, 298 2
PhD Dexter, BSc Sian, PhD Rose, BSc Hindmarsh, PhD” Mann, PhD Cooper, MAOxon Wells, MRCPath Daniel, Frcp Lees, MD Schapira, DSc Jenner, Frs Marsden (1994)
Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body diseaseAnnals of Neurology, 35
G. Davey, J. Clark (1996)
Threshold Effects and Control of Oxidative Phosphorylation in Nonsynaptic Rat Brain MitochondriaJournal of Neurochemistry, 66
E. Sofić, K. Lange, K. Jellinger, P. Riederer (1992)
Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's diseaseNeuroscience Letters, 142
P. Lapchak, P. Miller, F. Collins, S. Jiao (1997)
Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: comparison of intraventricular and intranigral deliveryNeuroscience, 78
PhD Jenner, M. Olanow, Prof Jenner, Pharmacology Group (1998)
Understanding cell death in parkinson's diseaseAnnals of Neurology, 44
Joseph Steiner, Gregory Hamilton, Douglas Ross, Heather Valentine, Hongzhi Guo, Maureen Connolly, Shi Liang, Cynthia Ramsey, Jia-He Li, Wei Huang, Pamela Howorth, Raj Soni, Mike Fuller, Hans Sauer, Alison Nowotnik, Peter Suzdak (1997)
Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models.Proceedings of the National Academy of Sciences of the United States of America, 94 5
L. Turski, K. Bressler, K. Rettig, P. Löschmann, H. Wachtel (1991)
Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonistsNature, 349
K. Castagnoli, S. Palmer, A. Anderson, T. Bueters, N. Castagnoli (1997)
The neuronal nitric oxide synthase inhibitor 7-nitroindazole also inhibits the monoamine oxidase-B-catalyzed oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.Chemical research in toxicology, 10 4
(1998)
P1: ARS/vks P2: ARS/plb QC: ARS/abe T1: ARS December 18
P. Mcgeer, M. Schulzer, E. Mcgeer (1996)
Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's diseaseNeurology, 47
W. Tatton, W. Ju, J. Wadia, N. Tatton (1996)
Reduction of neuronal apoptosis by small molecules: Promise for new approaches to neurological therapy
Lichtman
G. Kroemer, P. Petit, N. Zamzami, J. Vayssiere, B. Mignotte (1995)
The biochemistry of programmed cell deathThe FASEB Journal, 9
X. Liu, C. Kim, Jie Yang, R. Jemmerson, Xiaodong Wang (1996)
Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome cCell, 86
S. Desagher, J. Glowinski, J. Prémont (1996)
Astrocytes protect neurons from hydrogen peroxide toxicity, 16
C. Mytilineou, Shan‐Kuo Han, G. Cohen (1993)
Toxic and Protective Effects of l‐DOPA on Mesencephalic Cell CulturesJournal of Neurochemistry, 61
L. Maroteaux, JT Campanelli, R. Scheller (1988)
Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal, 8
J. Greenamyre, R. Eller, Zhiming Zhang, Aliza Ovadia, R. Kurlan, D. Gash (1994)
Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's diseaseAnnals of Neurology, 35
H. Mochizuki, K. Goto, H. Mori, Y. Mizuno (1996)
Histochemical detection of apoptosis in Parkinson's diseaseJournal of the Neurological Sciences, 137
N. Wood (1998)
Genetic risk factors in parkinson's diseaseAnnals of Neurology, 44
P. Good, A. Hsu, P. Werner, D. Perl, C. Olanow (1998)
Protein Nitration in Parkinson's DiseaseJournal of Neuropathology and Experimental Neurology, 57
S. Hunot, B. Brugg, D. Ricard, P. Michel, M. Muriel, M. Ruberg, B. Faucheux, Y. Agid, E. Hirsch (1997)
Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease.Proceedings of the National Academy of Sciences of the United States of America, 94 14
C. Tanner, J. Langston, H. Klawans, C. Goetz, W. Koller, L. Golbe (1990)
Do environmental toxins cause Parkinson's disease? A critical reviewNeurology, 40
F. González-Scarano, G. Baltuch (1999)
Microglia as mediators of inflammatory and degenerative diseases.Annual review of neuroscience, 22
N. Francis, S. Landis (1999)
Cellular and molecular determinants of sympathetic neuron development.Annual review of neuroscience, 22
Olanow Cw (1990)
Oxidation reactions in Parkinson's disease.Neurology, 40
(1997)
Parkinson's disease (PD) concordance in elderly male monozygotic (MZ) and dizygotic (DZ) twins
H. Asada, N. Ip, Li Pan, N. Razack, M. Parfitt, R. Plunkett (1995)
Time course of ciliary neurotrophic factor mRNA expression is coincident with the presence of protoplasmic astrocytes in traumatized rat striatumJournal of Neuroscience Research, 40
A. Tomac, E. Lindqvist, L.-F. Lin, S. Ögren, D. Young, B. Hoffer, L. Olson (1995)
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivoNature, 373
E. Pileblad, T. Magnusson, B. Fornstedt (1989)
Reduction of Brain Glutathione by l‐Buthionine Sulfoximine Potentiates the Dopamine‐Depleting Action of 6‐Hydroxydopamine in Rat StriatumJournal of Neurochemistry, 52
B. Faucheux, Nathalie NILLESSEt, P. Damier, Genevieve SPIKt, A. Mouatt‐Prigent, Annick PIERCEt, Beatrice LEVEUGLEt, Nathalie Kubis, J. Hauw, Y. Agid, E. Hirsch (1995)
Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease.Proceedings of the National Academy of Sciences of the United States of America, 92 21
M. Beal (1992)
Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?Annals of Neurology, 31
N. Tatton, S. Kish (1997)
In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange stainingNeuroscience, 77
C. Olanow (1993)
A radical hypothesis for neurodegenerationTrends in Neurosciences, 16
J. Schulz, D. Henshaw, R. Matthews, M. Beal (1995)
Coenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicityExperimental Neurology, 132
J. Beckman, Tanya Beckman, Jun Chen, P. Marshall, B. Freeman (1990)
Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.Proceedings of the National Academy of Sciences of the United States of America, 87
J. George, Hui Jin, W. Woods, D. Clayton (1995)
Characterization of a novel protein regulated during the critical period for song learning in the zebra finchNeuron, 15
L.-F. Lin, D. Doherty, J. Lile, S. Bektesh, F. Collins (1993)
GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons.Science, 260 5111
池邊 神一郎 (1995)
Point mutations of mitochondrial genome in Parkinson's disease
W. Nicklas, I. Vyas, R. Heikkila (1985)
Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.Life sciences, 36 26
C. Mytilineou, P. Radcliffe, C. Olanow (1997)
l‐(−)‐Desmethylselegiline, a Metabolite of Selegiline [l‐(−)‐Deprenyl], Protects Mesencephalic Dopamine Neurons from Excitotoxicity In VitroJournal of Neurochemistry, 68
J. Temlett, J. Landsberg, F. Watt, G. Orime (1994)
Increased Iron in the Substantia Nigra Compacta of the MPTP‐Lesioned Hemiparkinsonian African Green Monkey: Evidence from Proton Microprobe Elemental MicroanalysisJournal of Neurochemistry, 62
P. Good, C. Olanow, D. Perl (1992)
Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA studyBrain Research, 593
(1994)
A marker of oxyradical-mediated DNA damage (8-hydroxy-2 deoxyguanosine) is increased in nigro-striatum of Parkinson's disease brain
K. Uéda, H. Fukushima, E. Masliah, Yu Xia, A. Iwai, M. Yoshimoto, D. Otero, J. Kondo, Y. Ihara, T. Saitoh (1993)
Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.Proceedings of the National Academy of Sciences of the United States of America, 90 23
PhD Hirsch, PhD Hunot, Faucheux PhD, Dr Hirsch (1998)
Glial cells and inflammation in parkinson's disease: A role in neurodegeneration?Annals of Neurology, 44
M. Grilli, M. Pizzi, M. Memo, P. Spano (1996)
Neuroprotection by Aspirin and Sodium Salicylate Through Blockade of NF-κB ActivationScience, 274
L. Golbe (1990)
The genetics of Parkinson's disease: A reconsiderationNeurology, 40
Gerson Chadi, Yihai Cao, Yihai Cao, Ralf Pettersson, Ralf Pettersson, K. Fuxe (1994)
Temporal and spatial increase of astroglial basic fibroblast growth factor synthesis after 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine neuronsNeuroscience, 61
P. Lestienne, J. Nelson, P. Riederer, K. Jellinger, H. Reichmann (1990)
Normal Mitochondrial Genome in Brain from Patients with Parkinson's Disease and Complex I DefectJournal of Neurochemistry, 55
C. Olanow, H. Klawans, W. Koller, J. Langston (1990)
Oxidation reactions in Parkinson's disease. DiscussionNeurology, 40
W. Tatton, W. Ju, D. Holland, C. Tai, M. Kwan (1994)
(−)‐Deprenyl Reduces PC12 Cell Apoptosis by Inducing New Protein SynthesisJournal of Neurochemistry, 63
D. Dexter, F. Wells, A. Lees, F. Agid, Y. Agid, P. Jenner, C. Marsden (1989)
Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's DiseaseJournal of Neurochemistry, 52
N. Ogawa, M. Asanuma, Y. Kondo, Y. Kawada, Mitsutoshi Yamamoto, A. Mori (1994)
Differential effects of chronic l-DOPA treatment on lipid peroxidation in the mouse brain with or without pretreatment with 6-hydroxydopamineNeuroscience Letters, 171
D. Newmeyer, D. Farschon, John Reed (1994)
Cell-free apoptosis in Xenopus egg extracts: Inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondriaCell, 79
J. Schulz, R. Matthews, M. Muqit, S. Browne, M. Beal (1995)
Inhibition of Neuronal Nitric Oxide Synthase by 7‐Nitroindazole Protects Against MPTP‐Induced Neurotoxicity in MiceJournal of Neurochemistry, 64
C. Hyman, M. Hofer, Y. Barde, M. Juhasz, G. Yancopoulos, S. Squinto, R. Lindsay (1991)
BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigraNature, 350
C. Troy, M. Shelanski (1994)
Down-regulation of copper/zinc superoxide dismutase causes apoptotic death in PC12 neuronal cells.Proceedings of the National Academy of Sciences of the United States of America, 91 14
D. Dexter, C. Carter, F. Wells, F. Javoy‐Agid, Y. Agid, A. Lees, P. Jenner, C. Marsden (1989)
Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's DiseaseJournal of Neurochemistry, 52
Y. Okuda, S. Sakoda, H. Fujimura, T. Yanagihara (1996)
Pentoxifylline delays the onset of experimental allergic encephalomyelitis in mice by modulating cytokine production in peripheral blood mononuclear cells.Immunopharmacology, 35 2
Jeswinder Sian, D. Dexter, A. Lees, S. Daniel, Y. Agid, F. Javoy‐Agid, P. Jenner, C. Marsden (1994)
Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal gangliaAnnals of Neurology, 36
MD Rodriguez, MD Obeso, MD Olanow, Str GPe, GPi Thalamus (1998)
Subthalamic nucleus‐mediated excitotoxicity in parkinson's disease: A target for neuroprotectionAnnals of Neurology, 44
Theo Hagg, Silvio Varon (1993)
Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra dopaminergic neurons in vivo.Proceedings of the National Academy of Sciences of the United States of America, 90 13
G. Crawford, WD Le, R.Glenn Smith, WJ Xie, E. Stefani, Sarit Appel (1992)
A novel N18TG2 x mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin, 12
T. Singer, N. Castagnoli, R. Ramsay, A. Trevor (1987)
Biochemical Events in the Development of Parkinsonism Induced by 1‐Methyl‐4‐Phenyl‐1,2,3,6‐TetrahydropyridineJournal of Neurochemistry, 49
M. Polymeropoulos (1998)
Autosomal dominant parkinson's disease and α‐synucleinAnnals of Neurology, 44
P. Weinreb, Weiguo Zhen, Anna Poon, K. Conway, P. Lansbury (1996)
NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded.Biochemistry, 35 43
J. Ham, Carol Babij, J. Whitfield, C. Pfarr, D. Lallemand, M. Yaniv, L. Rubin (1995)
A c-jun dominant negative mutant protects sympathetic neurons against programmed cell deathNeuron, 14
M. Spillantini, M. Schmidt, V. Lee, J. Trojanowski, R. Jakes, M. Goedert (1997)
α-Synuclein in Lewy bodiesNature, 388
N. Tatton, A. Maclean-Fraser, W. Tatton, D. Perl, C. Warren (1998)
A fluorescent double‐labeling method to detect and confirm apoptotic nuclei in parkinson's diseaseAnnals of Neurology, 44
(1923)
Wong 29 Making Brain Connections: Neuroanatomy and the Work of TPS Powell
A. Sawa, Adil Khan, L. Hester, S. Snyder (1997)
Glyceraldehyde-3-phosphate dehydrogenase: nuclear translocation participates in neuronal and nonneuronal cell death.Proceedings of the National Academy of Sciences of the United States of America, 94 21
R. Ishitani, M. Kimura, K. Sunaga, Nobuo Katsube, M. Tanaka, De-Maw Chuang (1996)
An antisense oligodeoxynucleotide to glyceraldehyde-3-phosphate dehydrogenase blocks age-induced apoptosis of mature cerebrocortical neurons in culture.The Journal of pharmacology and experimental therapeutics, 278 1
V. Dawson, T. Dawson, E. London, D. Bredt, S. Snyder (1991)
Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures.Proceedings of the National Academy of Sciences of the United States of America, 88 14
(1992)
Downloaded from arjournals.annualreviews.org by KENYON COLLEGE LIBRARIES on 03/25/05. For personal use only
J. Wadia, R. Chalmers-Redman, R. Chalmers-Redman, W. Ju, G. Carlile, J. Phillips, A. Fraser, A. Fraser, W. Tatton, W. Tatton (1998)
Mitochondrial Membrane Potential and Nuclear Changes in Apoptosis Caused by Serum and Nerve Growth Factor Withdrawal: Time Course and Modification by (−)-DeprenylThe Journal of Neuroscience, 18
J. Schall, K. Thompson (1999)
Neural selection and control of visually guided eye movements.Annual review of neuroscience, 22
P. Aisen, D. Marin, L. Altstiel, Catherine Goodwin, Bella Baruch, R. Jacobson, T. Ryan, K. Davis (1996)
A pilot study of prednisone in Alzheimer's disease.Dementia, 7 4
J. Connor, B. Snyder, P. Arosio, D. Loeffler, P. LeWitt (1995)
A Quantitative Analysis of Isoferritins in Select Regions of Aged, Parkinsonian, and Alzheimer's Diseased BrainsJournal of Neurochemistry, 65
B. Piallat, A. Benazzouz, A. Benabid (1996)
Subthalamic Nucleus Lesion in Rats Prevents Dopaminergic Nigral Neuron Degeneration After Striatal 6‐OHDA Injection: Behavioural and Immunohistochemical StudiesEuropean Journal of Neuroscience, 8
A. Yoritaka, N. Hattori, K. Uchida, Masashi Tanaka, E. Stadtman, Y. Mizuno (1996)
Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease.Proceedings of the National Academy of Sciences of the United States of America, 93 7
Y. Mizuno, S. Matuda, H. Yoshino, H. Mori, N. Hattori, S. Ikebe (1994)
An immunohistochemical study on α‐ketoglutarate dehydrogenase complex in Parkinson's diseaseAnnals of Neurology, 35
S. Przedborski, V. Jackson-Lewis, Rina Yokoyama, T. Shibata, V. Dawson, T. Dawson (1996)
Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity.Proceedings of the National Academy of Sciences of the United States of America, 93 10
S. Dimauro (1993)
Mitochondria1 involvement in Parkinson's diseaseNeurology, 43
P. Bernardi, R. Colonna, P. Costantini, O. Eriksson, E. Fontaine, F. Ichas, S. Massari, A. Nicolli, V. Petronilli, L. Scorrano (2022)
The mitochondrial permeability transitionBioFactors, 8
G. Sengstock, C. Olanow, A. Dunn, S. Barone, G. Arendash (1994)
Progressive Changes in Striatal Dopaminergic Markers, Nigral Volume, and Rotational Behavior Following Iron Infusion into the Rat Substantia NigraExperimental Neurology, 130
P. Mombaerts (1999)
Molecular biology of odorant receptors in vertebrates.Annual review of neuroscience, 22
MD Olanow, MD Hauser, BSc Gauger, RN Malapira, W. Koller, MD Hubble, RN Bushenbark, MD Lilienfeld, Mso Esterlitz, C. Olanow, Gauger RA, Dr Olanow (1995)
The effect of deprenyl and levodopa on the progression of Parkinson's diseaseAnnals of Neurology, 38
BSc Sian, PhD Dexter, Frcp Lees, MRCPath Daniel, DSc Jenner, Frs Marsden, Deborah Jenner, Biomembrane Group, Manresa London, Road (1994)
Glutathione‐related enzymes in brain in Parkinson's diseaseAnnals of Neurology, 36
P. Hantraye, E. Brouillet, R. Ferrante, S. Palfi, R. Dolan, R. Matthews, M. Beal (1996)
Inhibition of neuronal nitric oxide synthase prevents MPTP–induced parkinsonism in baboonsNature Medicine, 2
G. Walkinshaw, C. Waters (1995)
Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson's disease.The Journal of clinical investigation, 95 6
J. Neural Transm
W. Tatton, R. Chalmers-Redman, W. Ju, J. Wadia, N. Tatton (1997)
Apoptosis in neurodegenerative disorders: potential for therapy by modifying gene transcription.Journal of neural transmission. Supplementum, 49
T. Hagg, D. Quon, J. Higaki, S. Varon (1992)
Ciliary neurotrophic factor prevents neuronal degeneration and promotes low affinity NGF receptor expression in the adult rat CNSNeuron, 8
M. DeLong (1990)
Primate models of movement disorders of basal ganglia originTrends in Neurosciences, 13
W. Koller, C. Olanow, R. Rodnitzky, J. Fink, J. Growdon, G. Paulson, R. Kurlan, J. Friedman, S. Gancher, J. Nutt, A. Rajput, J. Bennett, G. Wooten, P. LeWitt, C. Goetz, C. Tanner, K. Shannon, O. Suchowersky, M. Brin (1993)
Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease.The New England journal of medicine, 328 3
O. Bandmann, J. Vaughan, P. Holmans, C. Marsden, N. Wood (1997)
Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's diseaseThe Lancet, 350
Kevin Scotcher, I. Irwin, L. Delanney, J. Langston, D. Monte (1990)
Effects of 1‐Methyl‐4‐Phenyl‐ 1,2,3,6‐Tetrahydropyridine and 1 ‐Methyl‐4‐Phenylpyridinium Ion on ATP Levels of Mouse Brain SynaptosomesJournal of Neurochemistry, 54
G. Sengstock, C. Olanow, R. Menzies, A. Dunn, G. Arendash (1993)
Infusion of iron into the rat substantia nigra: Nigral pathology and dose‐dependent loss of striatal dopaminergic markersJournal of Neuroscience Research, 35
B. Halliwell, J. Gutteridge (1985)
Oxygen radicals and the nervous systemTrends in Neurosciences, 8
B. Mueller (1999)
Growth cone guidance: first steps towards a deeper understanding.Annual review of neuroscience, 22
J. Bolaños, S. Heales, S. Peuchen, J. Barker, J. Land, J. Clark (1996)
Nitric oxide-mediated mitochondrial damage: a potential neuroprotective role for glutathione.Free radical biology & medicine, 21 7
Z. Alam, A. Jenner, S. Daniel, A. Lees, Nigel Cairns, C. Marsden, P. Jenner, B. Halliwell (1997)
Oxidative DNA Damage in the Parkinsonian Brain: An Apparent Selective Increase in 8‐Hydroxyguanine Levels in Substantia NigraJournal of Neurochemistry, 69
A. Cochilla, J. Angleson, William Betz (1999)
Monitoring secretory membrane with FM1-43 fluorescence.Annual review of neuroscience, 22
D. Gash, Zhiming Zhang, W. Cass, Aliza Ovadia, L. Simmerman, D. Martin, D. Russell, F. Collins, B. Hoffer, Greg Gerhardt (1995)
Morphological and functional effects of intranigrally administered GDNF in normal rhesus monkeysJournal of Comparative Neurology, 363
B. Wandell (1999)
Computational neuroimaging of human visual cortex.Annual review of neuroscience, 22
E. Oestreicher, G. Sengstock, P. Riederer, C. Olanow, A. Dunn, G. Arendash (1994)
Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical studyBrain Research, 660
J. Neurochem
M. Polymeropoulos, C. Lavedan, E. Leroy, S. Ide, A. Dehejia, A. Dutra, B. Pike, H. Root, J. Rubenstein, R. Boyer, E. Stenroos, S. Chandrasekharappa, A. Athanassiadou, T. Papapetropoulos, W. Johnson, A. Lazzarini, R. Duvoisin, G. Iorio, L. Golbe, R. Nussbaum (1997)
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 276
M. Mogi, M. Harada, T. Kondo, Y. Mizuno, H. Narabayashi, Peter Riedere, T. Nagatsu (1996)
bcl-2 Protein is increased in the brain from parkinsonian patientsNeuroscience Letters, 215
▪ Abstract Parkinson's disease (PD) is an age-related neurodegenerative disorder that affects approximately 1 million persons in the United States. It is characterized by resting tremor, rigidity, bradykinesia or slowness, gait disturbance, and postural instability. Pathological features include degeneration of dopaminergic neurons in the substantia nigra pars compacta coupled with intracytoplasmic inclusions known as Lewy bodies. Neurodegeneration and Lewy bodies can also be found in the locus ceruleus, nucleus basalis, hypothalamus, cerebral cortex, cranial nerve motor nuclei, and central and peripheral components of the autonomic nervous system. Current treatment consists of a dopamine replacement strategy using primarily the dopamine precursor levodopa. While levodopa provides benefit to virtually all PD patients, after 5–10 years of treatment the majority of patients develop adverse events in the form of dyskinesia (involuntary movements) and fluctuations in motor response. Further, disease progression is associated with the development of dementia, autonomic dysfunction, and postural instability, which do not respond to levodopa therapy. Accordingly, research efforts have been directed toward understanding the etiology and pathogenesis of PD in the hope of developing a more effective therapy that will slow or halt the natural progression of PD. This paper reviews recent advances.
Annual Review of Neuroscience – Annual Reviews
Published: Mar 1, 1999
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.